论文部分内容阅读
目的:研究活血消异方联合GnRH-a对气滞血瘀型子宫内膜异位症术后复发的影响。方法:将72例气滞血瘀型子宫内膜异位症患者随机分为观察组和对照组各36例,观察组患者术后采用活血消异方联合GnRH-a治疗,对照组患者仅采用GnRH-a治疗,观察比较两组患者术后复发率及不良反应情况。结果:观察组患者术后复发率、不良反应发生率均显著低于对照组,差异具有统计学意义(P<0.05)。结论:活血消异方联合GnRH-a治疗气滞血瘀型子宫内膜异位症患者可有效预防术后复发,具有较高的安全性,值得临床推广应用。
Objective: To study the effect of Huoxuexianfang combined with GnRH-a on recurrence of endometriosis with qi stagnation and blood stasis type. Methods: 72 cases of qi stagnation and blood stasis type endometriosis patients were randomly divided into observation group and control group, 36 cases in the observation group were treated with Huoxuexifang combined with GnRH-a treatment, the control group of patients with only GnRH-a treatment, observation and comparison of the two groups of patients relapse rate and adverse reactions. Results: The recurrence rate and the incidence of adverse reactions in the observation group were significantly lower than those in the control group (P <0.05). Conclusion: Huoxuexianfang combined with GnRH-a can effectively prevent postoperative recurrence in patients with qi stagnation and blood stasis type endometriosis, which is safe and worthy of clinical application.